African Bio Developments
ActiveSummary
The computed 12-month bankruptcy probability of African Bio Developments is 2.9% (moderate). The 2025 annual accounts show negative equity (-€44,901) and a net result of -€11,027. Equity is shrinking by about 27% per year across the filed financial years. Its solvency ranks better than 5% of 50 sector peers (NACE 39, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
22-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
22-12
NBB filing
Annual accounts filed
financial year 2024 · micro format · 144 days late
26-06
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
Gazette deed
Registered office
Registered-office move · Director in office3 facts ▸
- Registered-office move, 2160 Wommeigem, Nijverheidsstraat 70
- Board meeting, 28-03-2025
- Director in office, Jacques Jespers (director)
2024
24-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Weakest financial yearnet -€11,648
Net result drops to -€11,648, the lowest in the series; recovery starts the following year.
23-10
NBB filing
Annual accounts filed
financial year 2022 · micro format · 84 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.